[1] Lehrman MA, Schneider WJ, Südhof TC, Brown MS, Goldstein JL, Russell DW. Mutation in LDL receptor: Alu- Alu recombination deletes exons encoding transmembrane and cytoplasmic domains. Science, 1985, 227(4683): 140–146.

[2] 唐新, 林婴, 刘兵, 马誓, 杨洋, 杨正林. 家族性高甘油三酯血症家系的候选基因位点连锁分析. 中华医学遗传学杂志, 2009, 26(5): 499–503.

[3] Garcia CK, Wilund K, Arca M, Zuliani G, Fellin R, Maioli M, Calandra S, Bertolini S, Cossu F, Grishin N, Barnes R, Cohen JC, Hobbs HH. Autosomal recessive hypercholes-terolemia caused by mutations in a putative LDL receptor adaptor protein. Science, 2001, 292(5520): 1394–8.

[4] Abifadel M, Varret M, Rabès JP, Allard D, Ouguerram K, Devillers M, Cruaud C, Benjannet S, Wickham L, Erlich D, Derré A, Villéger L, Farnier M, Beucler I, Bruckert E, Chambaz J, Chanu B, Lecerf JM, Luc G, Moulin P, Weissenbach J, Prat A, Krempf M, Junien C, Seidah NG, Boileau C. Mutations in PCSK9 cause autosomal dominant hypercholesterolemia. Nat Genet, 2003, 34(2): 154–156.

[5] Brown MS, Goldstein JL. A receptor-mediated pathway for cholesterol homeostasis. Science, 1986, 232(4746): 34–47.

[6] Soria LF, Ludwig EH, Clarke HR, Vega GL, Grundy SM, McCarthy BJ. Association between a specific apolipopro-tein B mutation and familial defective apolipoprotein B-100. Proc. Proc Natl Acad Sci USA, 1989, 86(2): 587– 591.

[7] Cohen JC, Boerwinkle E, Mosley TH Jr, Hobbs HH. Se-quence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med, 2006, 354(12): 1264–1272.

[8] Kryukov GV, Pennacchio LA, Sunyaev SR. Most rare missense alleles are deleterious in humans: implications for complex disease and association studies. Am J Hum Genet, 2007, 80(4): 727–739.

[9] Stenson PD, Mort M, Ball EV, Howells K, Phillips AD, Thomas NS, Cooper DN. The Human Gene Mutation Da-tabase: 2008 update. Genome Med, 2009, 1(1): 13.

[10] Ng SB, Buckingham KJ, Lee C, Bigham AW, Tabor HK, Dent KM, Huff CD, Shannon PT, Jabs EW, Nickerson DA, Shendure J, Bamshad MJ. Exome sequencing identifies the cause of a mendelian disorder. Nat Genet, 2010, 42(1): 30–35.

[11] Musunuru K, Pirruccello JP, Do R, Peloso GM, Guiducci C, Sougnez C, Garimella KV, Fisher S, Abreu J, Barry AJ, Fennell T, Banks E, Ambrogio L, Cibulskis K, Kernytsky A, Gonzalez E, Rudzicz N, Engert JC, DePristo MA, Daly MJ, Cohen JC, Hobbs HH, Altshuler D, Schonfeld G, Ga-briel SB, Yue P, Kathiresan S. Exome sequencing, ANGPTL3 mutations, and familial combined hypolipide-mia. N Engl J Med, 2010, 363(23): 2220–2227.

[12] Burnett JR, Shan J, Miskie BA, Whitfield AJ, Yuan J, Tran K, McKnight CJ, Hegele RA, Yao ZM. A novel nontrun-cating APOB gene mutation, R463W, causes familial hypobetalipoproteinemia. J Biol Chem, 2003, 278: 13442– 13452.

[13] Innerarity TL, Mahley RW, Weisgraber KH, Bersot TP, Krauss RM, Vega GL, Grundy SM, Friedl W, Davignon J, McCarthy BJ. Familial defective apolipoprotein B-100: a mutation of apolipoprotein B that causes hypercholes-terolemia. J Lipid Res, 1990, 31: 1337–1349.

[14] Hobbs HH, Leitersdorf E, Leffert CC, Cryer DR, Brown MS, Goldstein JL. Evidence for a dominant gene that suppresses hypercholesterolemia in a family with defec-tive low density lipoprotein receptors. J Clin Invest, 1989, 84(2): 656–664.

[15] Johansen CT, Wang J, Lanktree MB, Cao HN, McIntyre AD, Ban MR, Martins RA, Kennedy BA, Hassell RG, Visser ME, Schwartz SM, Voight BF, Elosua R, Salomaa V, O'Donnell CJ, Dallinga-Thie GM, Anand SS, Yusuf S, Huff MW, Kathiresan S, Hegele RA. Excess of rare vari-ants in genes identified by genome-wide association study of hypertriglyceridemia. Nat Genet, 2010, 42(8): 684–687.

[16] Teslovich TM, Musunuru K, Smith AV, Edmondson AC. Biological, clinical and population relevance of 95 loci for blood lipids. Nature, 2010, 466(7307): 707– 713.

[17] Kathiresan S, Melander O, Guiducci C, Surti A, Burtt NP, Rieder MJ, Cooper GM, Roos C, Voight BF, Havulinna AS, Wahlstrand B, Hedner T, Corella D, Tai ES, Ordovas JM, Berglund G, Vartiainen E, Jousilahti P, Hedblad B, Taskinen MR, Newton-Cheh C, Salomaa V, Peltonen L, Groop L, Altshuler DM, Orho-Melander M. Six new loci associated with blood low-density lipoprotein cholesterol, high-density lipoprotein cholesterol or triglycerides in humans. Nat Genet, 2008, 40(2): 189–197.

[18] Kathiresan S, Willer CJ, Peloso GM, Demissie S, Musunuru K, Schadt EE, Kaplan L, Bennett D, Li Y, Tanaka T, Voight BF, Bonnycastle LL, Jackson AU, Crawford G, Surti A, Guiducci C, Burtt NP, Parish S, Clarke R, Zelenika D, Kubalanza KA, Morken MA, Scott LJ, Stringham HM, Galan P, Swift AJ, Kuusisto J, Berg-man RN, Sundvall J, Laakso M, Ferrucci L, Scheet P, Sanna S, Uda M, Yang Q, Lunetta KL, Dupuis J, de Bak-ker PI, O'Donnell CJ, Chambers JC, Kooner JS, Hercberg S, Meneton P, Lakatta EG, Scuteri A, Schlessinger D, Tuomilehto J, Collins FS, Groop L, Altshuler D, Collins R, Lathrop GM, Melander O, Salomaa V, Peltonen L, Orho-Melander M, Ordovas JM, Boehnke M, Abecasis GR, Mohlke KL, Cupples LA. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet, 2009, 41(1): 56–65.

[19] Pollin TI, Damcott CM, Shen H, Ott SH, Shelton J, Horenstein RB, Post W, McLenithan JC, Bielak LF, Peyser PA, Mitchell BD, Miller M, O'Connell JR, Shuldiner AR. A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection. Sci-ence, 2008, 322(5908): 1702–1705.

[20] Willer CJ, Sanna S, Jackson AU, Scuteri A, Bonnycastle LL, Clarke R, Heath SC, Timpson NJ, Najjar SS, Stringham HM, Strait J, Duren WL, Maschio A, Busonero F, Mulas A, Albai G, Swift AJ, Morken MA, Narisu N, Bennett D, Parish S, Shen H, Galan P, Meneton P, Hercberg S, Zelenika D, Chen WM, Li Y, Scott LJ, Scheet PA, Sundvall J, Watanabe RM, Nagaraja R, Ebrahim S, Lawlor DA, Ben-Shlomo Y, Davey-Smith G, Shuldiner AR, Collins R, Bergman RN, Uda M, Tuomilehto J, Cao A, Collins FS, Lakatta E, Lathrop GM, Boehnke M, Schlessinger D, Mohlke KL, Abecasis GR. Newly identi-fied loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet, 2008, 40(2): 161–169.

[21] Zhou L, Ding H, Zhang XM, He MA, Huang SL, Xu YJ, Shi Y, Cui GL, Cheng LX, Wang QK, Hu FB, Wang DW, Wu TC. Genetic variants at newly identified lipid loci are associated with coronary heart disease in a Chinese Han population. PLoS ONE, 2011, 6(11): e27481.

[22] Zhuang K, Zhang WC, Zhang XB, Wu FQ, Cheng LX. Effects of SNPs at newly identified lipids loci on blood li-pid levels and risk of coronary heart disease in Chinese Han population: a case control study. J Huazhong Univ Sci Technolog Med Sci, 2011, 31(4): 452–456.

[23] Musunuru K, Strong A, Frank-Kamenetsky M, Lee NE, Ahfeldt T, Sachs KV, Li XY, Li H, Kuperwasser N, Ruda VM, Pirruccello JP, Muchmore B, Prokunina-Olsson L, Hall JL, Schadt EE, Morales CR, Lund-Katz S, Phillips MC, Wong J, Cantley W, Racie T, Ejebe KG, Orho- Melander M, Melander O, Koteliansky V, Fitzgerald K, Krauss RM, Cowan CA, Kathiresan S, Rader DJ. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature, 2010, 466(7307): 714–719.

[24] Holdt LM, Teupser D. Recent studies of the human chro-mosome 9p21 locus, which is associated with atheroscle-rosis in human populations. Arterioscler Thromb Vasc Biol, 2012, 32(2): 196–206.

[25] Harismendy O, Notani D, Song X, Rahim NG, Tanasa B, Heintzman N, Ren B, Fu XD, Topol EJ, Rosenfeld MG, Frazer KA. 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature, 2011, 470(7333): 264–268.

[26] Raychaudhuri S. Mapping rare and common causal alleles for complex human diseases. Cell, 2011, 147(1): 57–69.

[27] Ernst J, Kheradpour P, Mikkelsen TS, Shoresh N, Ward LD, Epstein CB, Zhang XL, Wang L, Issner R, Coyne M, Ku MC, Durham T, Kellis M, Bernstein BE. Mapping and analysis of chromatin state dynamics in nine human cell types. Nature, 2011, 473(7345): 43–49.

[28] Schadt EE, Molony C, Chudin E, Hao K, Yang X, Lum PY, Kasarskis A, Zhang B, Wang SS, Suver C, Zhu J, Millstein J, Sieberts S, Lamb J, GuhaThakurta D, Derry J, Storey JD, Avila-Campillo I, Kruger MJ, Johnson JM, Rohl CA, van Nas A, Mehrabian M, Drake TA, Lusis AJ, Smith RC, Guengerich FP, Strom SC, Schuetz E, Rushmore TH, Ulrich R. Mapping the genetic architecture of gene ex-pression in human liver. PLoS Biol, 2008, 6(5): e107.

[29] Burkhardt R, Toh SA, Lagor WR, Birkeland A, Levin M, Li X, Robblee M, Fedorov VD, Yamamoto M, Satoh T, Akira S, Kathiresan S, Breslow JL, Rader DJ. Trib1 is a lipid- and myocardial infarction-associated gene that reg-ulates hepatic lipogenesis and VLDL production in mice. J Clin Invest, 2010, 120(12): 4410-4414.

[30] Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gib-son G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Na-ture, 2009, 461(7265): 747–753.

[31] Cohen JC, Kiss RS, Pertsemlidis A, Marcel YL, McPherson R, Hobbs HH. Multiple rare alleles contribute to low plasma levels of HDL cholesterol. Science, 2004, 305(5685): 869–872.